Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment

Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment

US Patent 10857209 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesizing transformations to relationalize data tables2025
Machine-learned predictive models and systems for data preparation recommendatio2024
Machine-learned predictive models and systems for data preparation recommendatio2022
EP4 antagonists2022
Multikinase inhibitors for use in the treatment of cancer2021
EP4 antagonists2021
Lipid hydrolysis therapy for atherosclerosis and related diseases2020
Facilitating data type detection using existing code2020
Compositions and methods for diagnosing lung cancers2020
Compositions and methods for diagnosing lung cancers2020
EP4 antagonists2019
Beverage bottle2017